V

VistaGen Therapeutics
D

VTGN

2.72000
USD
0.14
(5.43%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-4
Market Cap
75,734,228
OverviewSignalsIdeasNews
Related Instruments
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    G
    GERN
    -0.04000
    (-1.08%)
    3.66500 USD
    P
    PTN
    -0.11800
    (-11.03%)
    0.95200 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VRNA
    0.270
    (0.76%)
    35.660 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: VistaGen Therapeutics

Sector: Healthcare
Industry: Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.